$ Value
$0
Shares
55,000
Price
$0
Filed
Apr 7
Insider
Name
Schwendenman Andrew
Title
Chief Accounting Officer
CIK
0001977879
Roles
Transaction Details
Transaction Date
2026-04-01
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
55,000
Footnotes
Represents shares of the Issuer's common stock issuable upon settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on May 15, 2027 and the remainder will vest in three approximately equal annual installments thereafter until May 15, 2030, subject to the Reporting Person's continuous service to the Issuer. | 25% of the shares underlying this stock option vest on April 1, 2027, and the remainder of the shares underlying this stock option vest in 36 approximately equal monthly installments thereafter.
Filing Info
Schwendenman Andrew's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-01 | REPL | A | $0 |
| 2026-04-01 | REPL | A | $0 |
| 2025-05-20 | REPL | ▼ | $26K |
Other Insiders at REPL (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| SLATTERY JOSEPH P | — | — | 2026-04-01 |
| BAKER BROS. ADVISORS LP | — | — | 2026-04-01 |
| Astley-Sparke Philip | — | — | 2026-04-01 |
| Pucci Paolo | — | — | 2026-04-01 |
| Dhingra Kapil | — | — | 2026-04-01 |
| Balachandran Madhavan | — | — | 2026-04-01 |
| Weinand Dieter | — | — | 2026-04-01 |
|
Hill Emily Luisa
Chief Financial Officer
|
— | — | 2026-04-01 |
| Oliger Christy J. | — | — | 2026-04-01 |
|
Patel Sushil
Chief Executive Officer
|
— | — | 2026-04-01 |
|
Xynos Konstantinos
Chief Medical Officer
|
— | — | 2026-04-01 |
|
Schwendenman Andrew
Chief Accounting Officer
|
— | — | 2026-04-01 |
| Peeples-Dyer Veleka | — | — | 2026-04-01 |
|
Sarchi Christopher
Chief Commercial Officer
|
— | $52K | 2026-04-02 |